Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP.

Morgan TR, Osann K, Bottiglieri T, Pimstone N, Hoefs JC, Hu KQ, Hassanein T, Boyer TD, Kong L, Chen WP, Richmond E, Gonzalez R, Rodriguez LM, Meyskens FL.

Cancer Prev Res (Phila). 2015 Sep;8(9):864-72. doi: 10.1158/1940-6207.CAPR-15-0029. Epub 2015 Jun 30.

2.

Proactive case finding to improve concurrently curative and palliative care in patients with end-stage liver disease.

Walling AM, Schreibeis-Baum H, Pimstone N, Asch SM, Robinson L, Korlekar S, Lorenz K, Nwajuaku T, Rosenfeld K.

J Palliat Med. 2015 Apr;18(4):378-81. doi: 10.1089/jpm.2014.0265. Epub 2014 Dec 10.

3.

Roles and pitfalls of transplantation in human porphyria.

Pimstone NR.

Liver Transpl. 2005 Dec;11(12):1460-2. No abstract available.

4.

Recommendations for the diagnosis and treatment of the acute porphyrias.

Anderson KE, Bloomer JR, Bonkovsky HL, Kushner JP, Pierach CA, Pimstone NR, Desnick RJ.

Ann Intern Med. 2005 Mar 15;142(6):439-50. Review. Erratum in: Ann Intern Med. 2005 Aug 16;143(4):316.

PMID:
15767622
5.

"Wait-and-see": an alternative approach to managing acute hepatitis C with high-dose interferon-alpha monotherapy.

Pimstone NR, Pimstone D, Saicheur T, Powell J, Yu AS.

Ann Intern Med. 2004 Sep 21;141(6):W91-2. No abstract available.

PMID:
15381541
6.

Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C.

Chaudhari S, Park J, Anand BS, Pimstone NR, Dieterich DT, Batash S, Bini EJ.

Dig Dis Sci. 2004 Jun;49(6):1000-6.

PMID:
15309891
7.

Paraparesis, hypermanganesaemia, and polycythaemia: a novel presentation of cirrhosis.

Gospe SM Jr, Caruso RD, Clegg MS, Keen CL, Pimstone NR, Ducore JM, Gettner SS, Kreutzer RA.

Arch Dis Child. 2000 Nov;83(5):439-42.

8.

Utility of hepatitis C virus serotypes in predicting response to treatment of chronic hepatitis C. Consensus Interferon Study Group.

Keeffe EB, Dusheiko GM, James SP, Mullen KD, Everson GT, Pimstone NR, Donovan J, Albert D.

Cytokines Cell Mol Ther. 1999 Dec;5(4):207-10.

PMID:
10850384
9.

Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Study Group.

Jensen DM, Krawitt EL, Keeffe EB, Hollinger FB, James SP, Mullen K, Everson GT, Hoefs JC, Fromm H, Black M, Foust RT, Pimstone NR, Heathcote EJ, Albert D.

Am J Gastroenterol. 1999 Dec;94(12):3583-8.

PMID:
10606323
10.

Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group.

Lee WM, Reddy KR, Tong MJ, Black M, van Leeuwen DJ, Hollinger FB, Mullen KD, Pimstone N, Albert D, Gardner S.

Hepatology. 1998 Nov;28(5):1411-5.

PMID:
9794929
11.

Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.

Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, Tortorelli K, LeClair P, Mercurio MG, Lambrecht RW.

Hepatology. 1998 Jun;27(6):1661-9.

PMID:
9620340
12.

Acute renal failure associated with nonfulminant hepatitis A viral infection.

Faust RL, Pimstone N.

Am J Gastroenterol. 1996 Feb;91(2):369-72. Review.

PMID:
8607509
13.

Diagnostic performance of a receptor-binding radiopharmacokinetic model.

Vera DR, Stadalnik RC, Metz CE, Pimstone NR.

J Nucl Med. 1996 Jan;37(1):160-4.

14.

Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog.

Pimstone NR, Stadalnik RC, Vera DR, Hutak DP, Trudeau WL.

Hepatology. 1994 Oct;20(4 Pt 1):917-23.

PMID:
7927233
16.

Free radical mechanism of oxidation of uroporphyrinogen in the presence of ferrous iron.

Mukerji SK, Pimstone NR.

Arch Biochem Biophys. 1990 Sep;281(2):177-84.

PMID:
2168153
18.

Evidence for two uroporphyrinogen decarboxylase isoenzymes in human erythrocytes.

Mukerji SK, Pimstone NR.

Biochem Biophys Res Commun. 1987 Aug 14;146(3):1196-203.

PMID:
3619926
19.

Therapeutic efficacy of oral charcoal in congenital erythropoietic porphyria.

Pimstone NR, Gandhi SN, Mukerji SK.

N Engl J Med. 1987 Feb 12;316(7):390-3. No abstract available.

PMID:
3100953
20.

Histopathology of early and late human allograft rejection.

Ruebner BH, Pauly MP, Pimstone N, Ward RE.

Hepatology. 1987 Jan-Feb;7(1):203-4. No abstract available.

PMID:
3542779
22.
23.
25.

Hematologic and hepatic manifestations of the cutaneous porphyrias.

Pimstone NR.

Clin Dermatol. 1985 Apr-Jun;3(2):83-102. Review.

PMID:
3916835
26.
27.
28.

Utility of porphyrins and light in the diagnosis and treatment of malignancy.

Pimstone NR.

Hepatology. 1985 Mar-Apr;5(2):338-40. No abstract available.

PMID:
3156801
30.

Alcoholic liver disease.

Pimstone NR, French SW.

Med Clin North Am. 1984 Jan;68(1):39-56. Review.

PMID:
6361417
31.

Optimal photodynamic band of red light in hematoporphyrin derivative (HPD) photoradiation therapy of cancer.

Pimstone NR, Gandhi SN.

Prog Clin Biol Res. 1984;170:673-8. No abstract available.

PMID:
6241707
33.
34.

Splenic embolization monitored by the video dilution technique.

Porter BA, Frey CF, Link DP, Lantz BM, Pimstone NR.

AJR Am J Roentgenol. 1983 Nov;141(5):1063-5. No abstract available.

PMID:
6353891
35.
36.

Fibrolamellar hepatocarcinoma: radiology, management, and pathology.

Wong LK, Link DP, Frey CF, Ruebner RH, Tesluk H, Pimstone NR.

AJR Am J Roentgenol. 1982 Jul;139(1):172-5. No abstract available.

PMID:
6283868
37.

Porphyria cutanea tarda.

Pimstone NR.

Semin Liver Dis. 1982 May;2(2):132-42. Review. No abstract available.

PMID:
6753163
38.

Congenital erythropoietic porphyria, diminished activity of uroporphyrinogen decarboxylase and dyserythropoiesis.

Kushner JP, Pimstone NR, Kjeldsberg CR, Pryor MA, Huntley A.

Blood. 1982 Apr;59(4):725-37. No abstract available.

39.

Current status of medical treatment of gallstones.

Pimstone NR, Mok HY.

Surg Clin North Am. 1981 Aug;61(4):865-74. Review.

PMID:
7025296
40.

Activation of uroporphyrinogen decarboxylase by ferrous iron in porphyria cutanea tarda.

Blekkenhorst GH, Eales L, Pimstone NR.

S Afr Med J. 1979 Nov 24;56(22):918-20.

PMID:
515872
41.

Familial symptomatic porphyria in South Africa.

Day RS, Eales L, Pimstone NR.

S Afr Med J. 1979 Nov 24;56(22):909-13.

PMID:
515870
42.

The nature of hepatic cytochrone P-450 induced in hexachlorobenzene-fed rats.

Blekkenhorst GH, Eales L, Pimstone NR.

Clin Sci Mol Med. 1978 Nov;55(5):461-9.

PMID:
719999
43.

Erythrohepatic protoporphyria (EHP) in South Africa.

Eales L, Day RS, Pimstone NR.

Ann Clin Res. 1978 Aug;10(4):195-204. No abstract available.

PMID:
707968
44.

The diagnostic value of blood plasma porphyrin methyl ester profiles produced by quantitative TLC.

Day RS, Pimstone NR, Eales L.

Int J Biochem. 1978;9(12):897-904. No abstract available.

PMID:
744293
45.

The hepato-renal syndrome--a review.

Pimstone NR.

S Afr J Surg. 1976 Mar;14(1):27-30. No abstract available.

PMID:
1273704
46.

The hepatic lesion in protoporphyria (PP): preliminary studies of haem metabolism, liver structure and ultrastructure.

Pimstone NR, Webber BL, Blekkenhorst GH, Eales L.

Ann Clin Res. 1976;8 Suppl 17:122-32.

PMID:
1008482
47.

Hepatic haem metabolism in porphyria cutanea tarda (PCT): enzymatic studies and their relation to liver ultrastructure.

Blekkenhorst GH, Pimstone NR, Webber BL, Eales L.

Ann Clin Res. 1976;8 Suppl 17:108-21.

PMID:
1008481
48.

Enzymatic defects in hepatic porphyria. Preliminary observations in patients with porphyria cutanea tarda and variegate porphyria.

Pimstone NR, Blekkenhorst G, Eales L.

Enzyme. 1973;16(1):354-66. No abstract available.

PMID:
4791054
49.
50.

Enzymatic degradation of heme. Oxygenative cleavage requiring cytochrome P-450.

Tenhunen R, Marver H, Pimstone NR, Trager WF, Cooper DY, Schmid R.

Biochemistry. 1972 Apr 25;11(9):1716-20. No abstract available.

PMID:
4402159

Supplemental Content

Loading ...
Support Center